You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API bremelanotide

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing bremelanotide

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
AMAG Pharmaceuticals Inc	VYLEESI	bremelanotide	64011-701	GLYCERIN	2024-06-21
AMAG Pharmaceuticals Inc	VYLEESI	bremelanotide	64011-701	HYDROCHLORIC ACID	2024-06-21
AMAG Pharmaceuticals Inc	VYLEESI	bremelanotide	64011-701	SODIUM HYDROXIDE	2024-06-21
AMAG Pharmaceuticals Inc	VYLEESI	bremelanotide	64011-701	WATER	2024-06-21
Palatin Technologies	VYLEESI	bremelanotide	80064-141	GLYCERIN	2024-06-21
Palatin Technologies	VYLEESI	bremelanotide	80064-141	HYDROCHLORIC ACID	2024-06-21
Palatin Technologies	VYLEESI	bremelanotide	80064-141	SODIUM HYDROXIDE	2024-06-21
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for bremelanotide

Excipient focus: GLYCERIN

bremelanotide drug variants containing GLYCERIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AMAG Pharmaceuticals Inc	bremelanotide	64011-701
Palatin Technologies	bremelanotide	80064-141
>Company	>Ingredient	>NDC

bremelanotide drug variants not containing GLYCERIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

bremelanotide drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AMAG Pharmaceuticals Inc	bremelanotide	64011-701
Palatin Technologies	bremelanotide	80064-141
>Company	>Ingredient	>NDC

bremelanotide drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

bremelanotide drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AMAG Pharmaceuticals Inc	bremelanotide	64011-701
Palatin Technologies	bremelanotide	80064-141
>Company	>Ingredient	>NDC

bremelanotide drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

bremelanotide drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AMAG Pharmaceuticals Inc	bremelanotide	64011-701
Palatin Technologies	bremelanotide	80064-141
>Company	>Ingredient	>NDC

bremelanotide drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.